ReviewPulmonary pharmacology & therapeutics2021

Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19.

Sugin Lal Jabaris S et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.